TCRX - Tscan Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TCRX is currently covered by 4 analysts with an average price target of $8.32. This is a potential upside of $6.49 (354.64%) from yesterday's end of day stock price of $1.83.

Tscan Therapeutics's activity chart (see below) currently has 5 price targets and 29 ratings on display. The stock rating distribution of TCRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.33% with an average time for these price targets to be met of 66.5 days.

Highest price target for TCRX is $15, Lowest price target is $3, average price target is $9.25.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 08-Apr-2025. First documented stock forecast 10-Aug-2021.

Best performing analysts who are covering TCRX - Tscan Therapeutics:

David Nierengarten Andrew Fein Gil Blum Peter Lawson

Currently out of the existing stock ratings of TCRX, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$7.18 (394.51%)

$9

3 months 13 days ago
(08-Apr-2025)

0/8 (0%)

$7.82 (662.71%)

Buy

$3

$1.18 (64.84%)

$14

4 months 14 days ago
(07-Mar-2025)

1/3 (33.33%)

$1.02 (51.52%)

74

Buy

$15

$13.18 (724.18%)

$15

4 months 15 days ago
(06-Mar-2025)

0/11 (0%)

$12.98 (642.57%)

Buy

$10

$8.18 (449.45%)

$10

11 months 8 days ago
(13-Aug-2024)

2/5 (40%)

$4.14 (70.65%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TCRX (Tscan Therapeutics) average time for price targets to be met?

On average it took 66.5 days on average for the stock forecasts to be realized with a an average price target met ratio 18.33

Which analyst has the current highest performing score on TCRX (Tscan Therapeutics) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on TCRX (Tscan Therapeutics) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on TCRX (Tscan Therapeutics)?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on TCRX

Which analyst is the currently most bullish on TCRX (Tscan Therapeutics)?

Andrew Fein with highest potential upside - $13.18

Which analyst is the currently most reserved on TCRX (Tscan Therapeutics)?

Peter Lawson with lowest potential downside - $1.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?